Celularity Free Cash Flow (FCF) History (CELU)

Celularity reported −$6.6M in free cash flow for fiscal 2024, an increase of $33.2M from the previous fiscal year, with a free cash flow margin of −12.10%.

View full Celularity company overview

Celularity free cash flow by year

Celularity annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20242024-12-31−$6.6M$33.2M−12.10%
20232023-12-31−$39.7M$103.4M−174.49%
20222022-12-31−$143.1M−$26.8M−796.17%
20212021-12-31−$116.3M−$25.3M−545.11%
20202020-12-31−$91.0M−637.53%

Celularity free cash flow growth trends

Celularity's latest reported quarter, Q4 2024, generated $1.5M in free cash flow, an increase of $6.4M year over year.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review Celularity filings at SEC.gov ↗